Tcw Group Inc Intellia Therapeutics, Inc. Transaction History

Tcw Group Inc

  • $11.2 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$31.62 - $45.78 $981,295 - $1.42 Million
31,034 Added 57.73%
84,794 $2.68 Million
Q2 2023

Aug 14, 2023
BUY
$34.58 - $46.03 $41,807 - $55,650
1,209 Added 2.3%
53,760 $2.19 Million
Q1 2023

May 15, 2023
BUY
$33.3 - $44.82 $1.07 Million - $1.44 Million
32,072 Added 156.61%
52,551 $1.96 Million
Q4 2022

Feb 14, 2023
BUY
$33.21 - $62.69 $680,107 - $1.28 Million
20,479 New
20,479 $714,000

Others Institutions Holding NTLA

# of Institutions
324
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $744M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Tcw Group Inc Portfolio

Follow Tcw Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tcw Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email